Physician Wealth Advisors’s Lexicon Pharmaceuticals LXRX Stock Holding History

Physician Wealth Advisors’s Portfolio LXRX Stock Details LXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.39K	Hold	1,412	–	–	﹤0.01%	1275
2026 Q1	$2.2K	Hold	1,412	–	–	﹤0.01%	1311
2025 Q4	$1.62K	Hold	1,412	–	–	﹤0.01%	1383
2025 Q3	$1.91K	Hold	1,412	–	–	﹤0.01%	1252
2025 Q2	$1.34K	Buy	+1,412	New	+$915	﹤0.01%	1215

Other funds holding LXRX

CLOS

Compagnie Lombard Odier SCmA 1204 Geneva, Switzerland $9.25B AUM 27.04% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

UOTTAIMCU

University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $863M AUM 30.35% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

SPWM

Straight Path Wealth Management Jenison, Michigan $428M AUM 26.3% 1-Year Est. Return

FGA

Fortis Group Advisors Westwood, New Jersey $626M AUM 33.6% 1-Year Est. Return

LSA

Leonteq Securities AG Zurich, Switzerland $2.91B AUM 56.5% 1-Year Est. Return

Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return

IWA

Invera Wealth Advisors Bend, Oregon $186M AUM 34.94% 1-Year Est. Return

Physician Wealth Advisors's LXRX Position: Q2 2026 in Review

Physician Wealth Advisors held its Lexicon Pharmaceuticals (LXRX) position steady in Q2 2026 at 1,412 shares worth $3.39K. The position accounts for ﹤0.01% of the portfolio, ranked #1275.

Physician Wealth Advisors first reported a position in LXRX in Q2 2025 and has held it in 5 quarters since. 28 funds tracked by Wall St. Rank hold LXRX as of Q2 2026.

Physician Wealth Advisors held 1,412 shares of Lexicon Pharmaceuticals worth $3.39K as of Q2 2026.
Physician Wealth Advisors left its Lexicon Pharmaceuticals share count unchanged in Q2 2026.
Lexicon Pharmaceuticals made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q2 2026, its #1275 holding.
Physician Wealth Advisors first reported a position in Lexicon Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
28 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q2 2026.

Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.